keflex
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.00 | $60.28 (0%) | 🛒 Add to cart |
| 90 | $0.96 | $90.41 $86.40 (4%) | 🛒 Add to cart |
| 120 | $0.93 | $120.55 $111.51 (8%) | 🛒 Add to cart |
| 180 | $0.90 | $180.83 $162.75 (10%) | 🛒 Add to cart |
| 270 | $0.89 | $271.24 $239.10 (12%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $361.66 $318.46 (12%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.17 | $70.32 (0%) | 🛒 Add to cart |
| 90 | $1.12 | $105.48 $100.46 (5%) | 🛒 Add to cart |
| 120 | $1.10 | $140.65 $131.60 (6%) | 🛒 Add to cart |
| 180 | $1.08 | $210.97 $193.89 (8%) | 🛒 Add to cart |
| 270 | $1.05 | $316.45 $284.30 (10%) | 🛒 Add to cart |
| 360 | $1.04
Best per pill | $421.94 $375.72 (11%) | 🛒 Add to cart |
Similar products
Cephalexin, marketed under the brand name Keflex among others, is a first-generation cephalosporin antibiotic belonging to the beta-lactam class. It’s a bactericidal agent that interferes with bacterial cell wall synthesis, making it effective against a wide range of Gram-positive and some Gram-negative organisms. In clinical practice, it’s a workhorse antibiotic, frequently prescribed for common outpatient infections like skin and soft tissue infections, respiratory tract infections, and urinary tract infections. Its role in modern medicine is significant due to its relatively broad spectrum, good oral bioavailability, and generally favorable safety profile, though rising resistance patterns necessitate careful consideration before prescribing.
Key Components and Bioavailability of Keflex
Keflex’s active pharmaceutical ingredient is cephalexin monohydrate. It’s formulated for oral administration, available in capsules (250 mg, 500 mg), tablets, and an oral suspension for pediatric use. The monohydrate form enhances stability. Bioavailability is a key strength—oral administration results in nearly complete absorption from the gastrointestinal tract, with peak serum concentrations achieved within one hour. Food does not significantly impair absorption, though it may slightly delay the time to peak concentration. It’s not highly protein-bound (about 10-15%), which means a greater proportion of the drug is free to exert its antibacterial effect. The drug is primarily excreted unchanged in the urine, giving it excellent concentration in the urinary tract, which is crucial for treating UTIs.
Mechanism of Action of Keflex: Scientific Substantiation
Keflex works through a well-understood bactericidal mechanism. Like other beta-lactams, its core action is the inhibition of bacterial cell wall synthesis. It achieves this by binding to specific penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. These PBPs are enzymes (transpeptidases, carboxypeptidases) critical for the final stage of peptidoglycan cross-linking, which provides structural integrity to the cell wall. By binding to PBPs, Keflex inactivates them. This disruption halts the cross-linking process, leading to the formation of a weakened, defective cell wall. Because the internal osmotic pressure of the bacterium is much higher than its environment, the compromised wall can no longer contain it, leading to cell lysis and death. This is why it’s considered bactericidal—it kills bacteria rather than just inhibiting their growth. Its spectrum is broader than penicillin, particularly against beta-lactamase-producing staphylococci, though it’s hydrolyzed by many broader-spectrum beta-lactamases.
Indications for Use: What is Keflex Effective For?
Keflex is indicated for the treatment of infections caused by susceptible strains of designated microorganisms.
Keflex for Skin and Skin Structure Infections
It’s a first-line option for uncomplicated cellulitis, abscesses, and wound infections, particularly those caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes.
Keflex for Respiratory Tract Infections
Effective for community-acquired pneumonia and other lower respiratory infections caused by susceptible Streptococcus pneumoniae. It’s also used for streptococcal pharyngitis.
Keflex for Urinary Tract Infections (UTIs)
Due to its high renal excretion, it achieves good concentration in the urine, making it suitable for uncomplicated cystitis caused by E. coli, Proteus mirabilis, and Klebsiella pneumoniae.
Keflex for Bone Infections
Can be used for acute osteomyelitis caused by S. aureus or Proteus mirabilis, though often as a follow-up to IV therapy.
Keflex for Otitis Media
Used for acute otitis media caused by S. pneumoniae, Haemophilus influenzae, staphylococci, and streptococci.
Instructions for Use: Dosage and Course of Administration
Dosing is weight-based for children and fixed for adults, typically ranging from 250 mg to 1 gram every 6 to 12 hours. The duration of therapy depends on the infection site and severity but usually ranges from 7 to 14 days. It’s crucial to complete the entire prescribed course, even if symptoms improve, to prevent relapse and antibiotic resistance.
| Indication | Adult Dosage | Frequency | Duration | Notes |
|---|---|---|---|---|
| Uncomplicated Skin Infection | 500 mg | Every 12 hours | 7-14 days | With or without food |
| Streptococcal Pharyngitis | 500 mg | Every 12 hours | 10 days | Full course critical |
| Uncomplicated Cystitis | 500 mg | Every 12 hours | 7 days | |
| Moderate to Severe Infection | 1 g | Every 6-8 hours | Varies |
For pediatric patients, the typical dose is 25-50 mg/kg/day divided into 2-4 doses.
Contraindications and Drug Interactions with Keflex
The primary contraindication is a known hypersensitivity to cephalexin or any other cephalosporin. Caution is advised in patients with a history of severe penicillin allergy due to a small risk of cross-reactivity (estimated 5-10%). Use with caution in patients with significant renal impairment, requiring dose adjustment. The safety of Keflex during pregnancy and lactation is categorized as FDA Pregnancy Category B, meaning animal studies have not shown risk, but controlled human studies are lacking—it should be used only if clearly needed.
Significant drug interactions include:
- Probenecid: Concurrent use can decrease the renal tubular secretion of Keflex, leading to increased and prolonged blood levels.
- Metformin: Keflex may increase the serum concentration of metformin; monitoring is advised.
- Live Bacterial Vaccines (e.g., Typhoid): Antibiotics may diminish the therapeutic effect of these vaccines.
Common side effects are gastrointestinal (diarrhea, nausea, vomiting, dyspepsia) and hypersensitivity reactions (rash, urticaria). A serious side effect is Clostridioides difficile-associated diarrhea, which can range from mild diarrhea to fatal colitis.
Clinical Studies and Evidence Base for Keflex
The efficacy of Keflex is supported by decades of clinical use and numerous studies. A 2018 meta-analysis in the Journal of Antimicrobial Chemotherapy confirmed its non-inferiority to other common antibiotics for treating uncomplicated skin and soft tissue infections in the outpatient setting. For UTIs, a Cochrane review highlighted that a 3-7 day course of cephalexin is effective for uncomplicated cystitis, though resistance in E. coli is an increasing concern. Its role in streptococcal pharyngitis is well-established, with studies showing it eradicates the bacteria as effectively as penicillin, making it a valuable alternative for penicillin-allergic patients. However, the evidence landscape is shifting; newer studies are increasingly documenting resistance, particularly in community-acquired MRSA, which is not covered by Keflex, underscoring the need for culture and sensitivity testing when possible.
Comparing Keflex with Similar Products and Choosing a Quality Product
When comparing Keflex to other antibiotics, it sits in a specific niche.
- vs. Penicillin VK: Keflex has a broader spectrum, covering many penicillinase-producing staphylococci. It’s a go-to for skin infections where penicillin would fail.
- vs. Amoxicillin-clavulanate (Augmentin): Augmentin has a broader spectrum, covering anaerobes and beta-lactamase-producing H. influenzae and Moraxella, making it better for animal bites and some respiratory infections. However, it has a higher incidence of GI side effects, particularly diarrhea.
- vs. Cephalosporins: Compared to 2nd generation (e.g., cefuroxime), Keflex has less Gram-negative coverage. Compared to 3rd generation (e.g., ceftriaxone), it has no reliable activity against Gram-negatives like Pseudomonas.
When a generic is prescribed, it’s crucial to ensure it’s from a reputable, FDA-approved manufacturer. The chemical entity is identical, but differences in manufacturing processes and inactive ingredients can rarely affect bioavailability or cause allergic reactions in sensitive individuals.
Frequently Asked Questions (FAQ) about Keflex
What is the recommended course of Keflex to achieve results?
The typical course is 7 to 14 days, depending on the infection. For strep throat, a full 10-day course is mandatory to prevent rheumatic fever. Always complete the entire prescription.
Can Keflex be combined with alcohol?
It’s not recommended. While it doesn’t cause a disulfiram-like reaction as seen with some antibiotics, alcohol can impair immune function and worsen side effects like nausea and dizziness.
Can Keflex be combined with birth control?
There is a theoretical risk that antibiotics like Keflex could reduce the effectiveness of estrogen-containing oral contraceptives by altering gut flora and enterohepatic recirculation. While the risk is considered low, using a backup contraceptive method during the antibiotic course and for one week after is a prudent precaution.
Is Keflex effective for tooth infections?
It can be, if the causative bacteria are susceptible. Dental infections are often polymicrobial with anaerobes, for which Keflex has poor coverage. Amoxicillin-clavulanate or clindamycin are often preferred.
What should I do if I miss a dose of Keflex?
Take it as soon as you remember. If it’s almost time for the next dose, skip the missed dose and continue your regular schedule. Do not double the dose to catch up.
Conclusion: Validity of Keflex Use in Clinical Practice
Keflex remains a valid and valuable tool in the outpatient antibiotic arsenal. Its well-defined mechanism of action, proven efficacy for common community-acquired infections, and generally favorable safety profile support its continued use. However, its utility is increasingly challenged by bacterial resistance, particularly the rise of community-associated MRSA in skin infections and ESBL-producing organisms in UTIs. The risk-benefit profile is positive when used judiciously for susceptible organisms. The key to its effective future use lies in antimicrobial stewardship—reserving it for appropriate indications based on local resistance patterns and culture results whenever possible.
You know, I remember when I first started out, Keflex was the answer to everything in the clinic. We handed it out for every other skin rash and cough. Felt like a miracle drug. But then you start to see the cracks. I had this one patient, Sarah, a 28-year-old teacher, came in with what looked like a classic cellulitis on her shin. Red, warm, swollen. Textbook. I put her on Keflex 500mg BID. Three days later she’s back, worse. The redness had spread. I’ll admit, my first thought was non-compliance. I gave her the whole “you gotta finish the pills” speech. She swore she was taking them. We got a culture back—MRSA. Keflex was useless. That was a real wake-up call for me. It’s not just about knowing the drug; it’s about knowing what’s not in its wheelhouse.
The development of these protocols wasn’t smooth either. Our practice had a big internal debate about a year ago. The younger docs, fresh out of residency, were pushing to make doxycycline or Bactrim the first-line for all skin infections, arguing the MRSA rates were just too high. The senior partners, myself included, were hesitant. Keflex is cheaper, better tolerated for many. We butted heads for weeks. We finally settled on a compromise: Keflex first-line for non-purulent cellulitis in healthy patients, but if there’s an abscess or purulence, think MRSA coverage from the get-go. It was a practical, if imperfect, solution.
Another case that sticks with me is an elderly gentleman, Mr. Henderson, 82, with a UTI. His urine culture came back with an E. coli that was sensitive to Keflex, but he had moderate renal impairment. His previous doc had him on the standard 500mg BID. His creatinine was creeping up. We adjusted his dose down, and he did great. It’s those little things—the pharmacokinetics in special populations—that you only learn from seeing the same patient over time. He’s been my patient for five years now, and he still mentions how that simple dose adjustment made him feel so much better without the grogginess. He calls it his “goldilocks dose.” It’s a small thing, but it’s why you can’t just practice from a textbook. You have to follow these patients, see the long-term outcomes, the successes and the failures. That’s the real data.